Effects of neurotropic drugs on glucose metabolism in rat brain in vivo.
D000409:Alanine / Q000032:analysis; D000596:Amino Acids / Q000032:analysis*; D000613:Aminobutyrates / Q000032:analysis; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000032:analysis; D001921:Brain / Q000378:metabolism*; D002247:Carbon Isotopes; D002746:Chlorpromazine / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D005971:Glutamates / Q000032:analysis; D005973:Glutamine / Q000032:analysis; D005977:Glutarates / Q000032:analysis; D007490:Iproniazid / Q000494:pharmacology; D007651:Keto Acids / Q000032:analysis*; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology*; D011773:Pyruvates / Q000032:analysis; D051381:Rats
D000596:Amino Acids; D000613:Aminobutyrates; D002247:Carbon Isotopes; D005971:Glutamates; D005977:Glutarates; D007651:Keto Acids; D011773:Pyruvates; D005973:Glutamine; D001224:Aspartic Acid; D009020:Morphine; D000661:Amphetamine; D007490:Iproniazid; D010424:Pentobarbital; D005947:Glucose; D000409:Alanine; D002746:Chlorpromazine